UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. [_______])*
NANOGEN, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, PAR VALUE $0.001 PAR SHARE
--------------------------------------------------------------------------------
(Title of Class of Securities)
630075 10 9
--------------------------------------------------------------------------------
(CUSIP Number)
MARCH 5, 2004
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[x] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which could
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 9 Pages
13G
CUSIP NO. 630075 10 9 PAGE 2 OF 9 PAGES
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Sage Capital Growth, Inc.
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [_]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
New York
--------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES 0
-----------------------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 1,875,000 shares of Common Stock
-----------------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 0
-----------------------------------------------------------------
PERSON 8. SHARED DISPOSITIVE POWER
WITH See Row 6 above
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
See Row 6 above
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
Approximately 6.06% as of the date of this Statement. (Based on 26,669,215
shares of Common Stock issued and outstanding as of March 3, 2004 plus
4,250,000 shares of Common Stock issued on March 5, 2004.)
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------------
Page 2 of 9 Pages
13G
CUSIP NO. 630075 10 9 PAGE 3 OF 9 PAGES
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Mainfield Enterprises, Inc.
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [_]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
--------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES 0
-----------------------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 1,875,000 shares of Common Stock
-----------------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 0
-----------------------------------------------------------------
PERSON 8. SHARED DISPOSITIVE POWER
WITH See Row 6 above
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
See Row 6 above
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
Approximately 6.06% as of the date of this Statement. (Based on 26,669,215
shares of Common Stock issued and outstanding as of March 3, 2004 plus
4,250,000 shares of Common Stock issued on March 5, 2004.)
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------------
Page 3 of 9 Pages
ITEM 1.
(a) Name of Issuer
NANOGEN, INC.
(b) Address of Issuer's Principal Executive Offices:
10398 Pacific Center Court
San Diego, CA 92121
ITEM 2.
(a) Name of Persons Filing:
Sage Capital Growth, Inc. ("Sage")
Mainfield Enterprises, Inc. ("Mainfield")
(b) Address of Principal Business Office:
Sage:
660 Madison Avenue, 18th floor
New York, New York 10021
Mainfield:
Icaza, Gonzalez-Ruiz & Aleman (BVI) Trust Limited, Wickhams Cay I,
Vanterpool Plaza
P.O. Box 873, Road Town
Tortolla, British Virgin Islands
(c) Citizenship:
Sage:
New York
Mainfield:
British Virgin Islands
(d) Title of Class of Securities:
Common Stock, par value $0.001 per share
(e) CUSIP Number:
630075 10 9
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR
13D-2(B), CHECK WHETHER THE PERSON FILING IS A:
Page 4 of 9 Pages
(a) [ ] Broker or dealer registered under section 15 of the Act (15
U.S.C. 78o).
(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) [ ] Insurance company as defined in section 3(a)(19) of the Act
(15 U.S.C. 78c).
(d) [ ] Investment company registered under section 8 of the
Investment Company Act of 1940 (15 U.S.C 80a-8).
(e) [ ] An investment adviser in accordance with
ss.240.13d-1(b)(1)(ii)(E);
(f) [ ] An employee benefit plan or endowment fund in accordance with
ss.240.13d-1(b)(1)(ii)(F);
(g) [ ] A parent holding company or control person in accordance
with ss. 240.13d-1(b)(1)(ii)(G);
(h) [ ] A savings associations as defined in Section 3(b) of the
Federal Deposit Insurance Act (12 U.S.C. 1813);
(i) [ ] A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the Investment Company
Act of 1940 (15 U.S.C. 80a-3);
(j) [ ] Group, in accordance with ss.240.13d-1(b)(1)(ii)(J).
If this statement is filed pursuant to Rule 13d-1(c), check this box [X]
ITEM 4. OWNERSHIP
(a) Amount Beneficially Owned
1,875,000 shares of Common Stock
(b) Percent of Class
Approximately 6.06% as of the date of this Statement. (Based on
26,669,215 shares of Common Stock issued and outstanding as of
March 3, 2004 plus 4,250,000 shares of Common Stock issued on
March 5, 2004.)
(c) Number of shares as to which the person has:
(i) Sole power to vote or direct the vote:
0
Page 5 of 9 Pages
(ii) Shared power to vote or direct the vote:
See Item 4(a) above.
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
See Item 4(a) above.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
Inapplicable
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Pursuant to an investment management agreement between Mainfield
and Sage, Sage has the power to sell or vote on behalf of
Mainfield some or all of the shares of Common Stock to which this
report relates. Accordingly, under Rule 13d-3(a), Sage may be
deemed to be the beneficial owner of shares owned by Mainfield.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING
COMPANY
Inapplicable
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
See the Joint Filing Agreement attached hereto as an Exhibit.
ITEM 9. NOTICE OF DISSOLUTION OF THE GROUP
Inapplicable
ITEM 10. CERTIFICATION
Page 6 of 9 Pages
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and
are not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were
not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
Page 7 of 9 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated this 5th day of March, 2004
SAGE CAPITAL GROWTH, INC.
By: /s/Avi Vigder
--------------------------------
Name: Avi Vigder
Title: Authorized Signatory
MAINFIELD ENTERPRISES, INC.
By: /s/Avi Vigder
--------------------------------
Name: Avi Vigder
Title: Authorized Signatory
Page 8 of 9 Pages
JOINT FILING AGREEMENT
In accordance with rule 13d-1(k)(1) of the Securities Exchange Act of
1934, as amended, the undersigned hereby agree to the joint filing with each
other of the attached statement on Schedule 13G, and all amendments thereto, and
that such statement, and all amendments thereto, is made on behalf of each of
them.
IN WITNESS WHEREOF, the undersigned hereby executed this agreement on
March 5, 2004.
Sage Capital Growth, Inc.
By: /s/Avi Vigder
------------------------------
Name: Avi Vigder
Title: Authorized Signatory
Mainfield Enterprises, Inc.
By: /s/Avi Vigder
------------------------------
Name: Avi Vigder
Title: Authorized Signatory
Page 9 of 9 Pages